| anti-CCP | anti-cyclic citrullinated peptide |
| CVD | cardiovascular disease |
| DM | diabetes mellitus |
| DMARDs | disease-modifying antirheumatic drugs |
| eHealth | digital health |
| EHR | electronic health record |
| GCs | glucocorticoids |
| G-CSF | granulocyte colony-stimulating factor |
| GPs | general practitioners |
| IA | inflammatory arthritis |
| INF-gamma | interferon-gamma |
| IL-1 | interleukin-1 |
| IL-4 | interleukin-4 |
| IL-5 | interleukin-5 |
| IL-6 | interleukin-6 |
| IL-8 | interleukin-8 |
| IL-10 | interleukin-10 |
| IL-12 | interleukin-12 |
| IL-13 | interleukin-13 |
| IL-17 | interleukin-17 |
| IL-21 | interleukin-21 |
| IL-21 | interleukin-22 |
| IL-35 | interleukin-35 |
| MSK | musculoskeletal |
| MTX | methotrexate |
| NPs | nurse practitioners |
| PC | primary care |
| PsA | psoriatic arthritis |
| RA | rheumatoid arthritis |
| RANKL | receptor activator of nuclear factor kappa-Β |
| RCTs | randomized controlled trials |
| RF | rheumatoid factor |
| SpA | spondylarthritis |
| TGF-beta | transforming grow factor-beta |
| TNF-alfa | tumor necrosis factor-alfa |